Trial Profile
Clinical Trials Insight: 700008171
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2008
Price :
$35
*
At a glance
- Drugs Nesbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 16 Apr 2008 Development of nesbuvir has been discontinued due to safety issues, according to a ViroPharma media release.
- 18 Nov 2005 New trial record.